News from 60 degrees pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 09, 2018, 09:49 ET US Food and Drug Administration Approves ARAKODA™ (tafenoquine) tablets for oral use; First preventative antimalarial approved in almost two decades

60 Degrees Pharmaceuticals (60P) announced today the U.S. Food and Drug Administration (FDA) approval of ARAKODA™ (tafenoquine) tablets for the...


Jul 26, 2018, 18:13 ET US FDA Advisory Committee votes in favor of Tafenoquine for the prevention of malaria

60 Degrees Pharmaceuticals (60P) announced today that the Antimicrobial Drugs Advisory Committee (AMDAC) of the United States Food and Drug...


Feb 08, 2018, 09:03 ET 60° Pharmaceuticals (60P) Receives Priority Review Designation For Malaria Drug

60 Degrees Pharmaceuticals (60P) received Priority Review Designation from the United States Food and Drug Administration (USFDA) for Tafenoquine...


Jan 04, 2018, 09:45 ET 60 Degrees Pharmaceuticals Fast Tracked For Malaria Drug

60 Degrees Pharmaceuticals (60P) has received Fast Track designation from the United States Food and Drug Administration (USFDA) for the...


Aug 20, 2015, 11:05 ET 60 Degrees Pharmaceuticals to Begin Phase II Clinical Trials in Dengue Fever Patients

60 Degrees Pharmaceuticals, (60P), a company focused on development of therapeutics for tropical diseases, and Singapore General Hospital (SGH)...